Literature DB >> 5289712

Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine.

D H Ho, E Frei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5289712     DOI： 10.1002/cpt1971126944

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  72 in total

Review 1.  Critical compilation of terminal half-lives, percent excreted unchanged, and changes of half-life in renal and hepatic dysfunction for studies in humans with references.

Authors:  L A Pagliaro; L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1975-10

2.  Accelerated radiotherapy with concomitant ACNU/Ara-C for the treatment of malignant glioma.

Authors:  K Anders; G G Grabenbauer; U Schuchardt; R Fahlbusch; R Fietkau; R Sauer; P Krauseneck
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

3.  Modified nanoprecipitation method for preparation of cytarabine-loaded PLGA nanoparticles.

Authors:  Khushwant S Yadav; Krutika K Sawant
Journal:  AAPS PharmSciTech       Date:  2010-09-15       Impact factor: 3.246

Review 4.  Cytosine arabinoside in the treatment of acute myeloid leukemia: the role and place of high-dose regimens.

Authors:  W Hiddemann
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

Review 5.  Molecular mechanisms of drug resistance.

Authors:  J D Hayes; C R Wolf
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

6.  Film interface for drug testing for delivery to cells in culture and in the brain.

Authors:  Min D Tang-Schomer; David L Kaplan; Michael J Whalen
Journal:  Acta Biomater       Date:  2019-03-02       Impact factor: 8.947

7.  Toxicity of 1-(beta-D-arabinofuranosyl)cytosine after intravitreal injection in the rabbit eye.

Authors:  J J Diets-Ouwehand; R J de Keizer; G F Vrensen; S Groen-Jansen; J A van Best
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

8.  Chemosensitivity of malignant human brain tumors. Preliminary results.

Authors:  U Bogdahn
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

9.  Pharmacokinetics of cytosine arabinoside in patients with acute myeloid leukaemia.

Authors:  A L Harris; C Potter; C Bunch; J Boutagy; D J Harvey; D G Grahame-Smith
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

10.  PCR-based methods for CDA K27Q and A70T genotyping: genotypes and alleles distribution in a central Italy population.

Authors:  Francesco M Carpi; Silvia Vincenzetti; Daniela Micozzi; Alberto Vita; Valerio Napolioni
Journal:  Mol Biol Rep       Date:  2009-11-26       Impact factor: 2.316
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.